关键的问题是血液代用品能降低心肌梗死的面积吗？
Do approved blood substitutes reduce myocardial infarction size: is this the critical question?
传统的输血法不能完全解决临床医疗和战场急救等情况下存在的一些实际问题，血液代用品的研究应运而生。
There are some practical issues to traditional method to solve all the clinical transfusion medicine and battlefield first aid cases, so study of blood substitutes emerge.
采用可生物降解的高分子材料制备的血红蛋白纳米微囊是新一代的血液代用品，具有与天然红细胞相似的性质，是一种很有潜力的氧载体。
The biodegradable nanocapsules containing hemoglobin (Hb) have the similar characteristics to natural red blood cells, therefore as the potential to become a new form of oxygen carrier.
应用推荐